Share on Pinterest The FDA has approved biosimilars for macular degeneration treatment. recep-bg/Getty Images The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related ...

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

THE WOODLANDS, TX / ACCESSWIRE / April 30, 2024 / Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium (RPE) patch to cure Macular Degeneration ...

PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...

A new study in mice hints at the promise of an eventual alternative treatment option for the 'wet' version of age-related macular degeneration (AMD). Researchers determined in mice that an enzyme ...

ORLANDO, Fla. (Ivanhoe Newswire) - There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it happens when small deposits form under ...

Macular degeneration (MD) is characterised by the progressive breakdown of the macula, the portion of the retina responsible for sharp, central vision, leading to visual distortion or loss.

Macular degeneration and macular dystrophy are eye conditions affecting the center of the retina. Although they share overlapping symptoms, their root causes and treatments differ. Macular ...

The choice to get treatment for the wet form of age-related macular degeneration (AMD) is a no-brainer. You have to get shots to save your vision. Fast intervention may even improve your eyesight. And ...

Geographic atrophy (GA) is one of two kinds of advanced age-related macular degeneration (AMD). It’s an eye disease that damages cells in the central part of your retina called the macula. Late-stage ...